COX JOHN (CEO & President) sold 0.9% of their position (3.31K shares) of DYNE THERAPEUTICS, INC. on the open market
Open‑market sale worth $60.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/14/2026ACC: 0001193125-26-223955
DirectorOfficer· CEO & President
Since Mar 2026
-3.31K
Net shares
Net seller
$60.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.31K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.31K
Price / share
$18.36
Trade value
$60.79K
% of position
0.9%
5/13/2026
374.14K→370.83K
Total
Net shares
−3.31K
Net value
-$60.79K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/13/2026 | S · Sale | −3.31K | $18.36 | $60.79K | 0.9% | 374.14K | 370.83K |
| Total | −3.31K | -$60.79K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned18K
Common Stock
IndirectShares owned18K
Common Stock
IndirectShares owned18K
Common Stock
IndirectShares owned18K
Total
72K indirect72K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 18K | Indirect |
| Common Stock | 18K | Indirect |
| Common Stock | 18K | Indirect |
| Common Stock | 18K | Indirect |
| Total | 72K | 72K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported